134 related articles for article (PubMed ID: 20359488)
21. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors.
Arellano Y; Bratoeff E; Garrido M; Soriano J; Heuze Y; Cabeza M
Steroids; 2011 Nov; 76(12):1241-6. PubMed ID: 21729714
[TBL] [Abstract][Full Text] [Related]
22. New aromatic esters of progesterone as antiandrogens.
Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
[TBL] [Abstract][Full Text] [Related]
23. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
[TBL] [Abstract][Full Text] [Related]
24. Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells.
Lo S; King I; Alléra A; Klingmüller D
Toxicol In Vitro; 2007 Apr; 21(3):502-8. PubMed ID: 17218080
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and pharmacological evaluation of new steroidal 5 alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Flores E; Ramirez E; Quiroz A; Heuze I
Proc West Pharmacol Soc; 2002; 45():187-90. PubMed ID: 12434577
[No Abstract] [Full Text] [Related]
26. Indole derivatives as a new class of steroid 5 alpha-reductase inhibitors.
Takami H; Koshimura H; Kishibayashi N; Ishii A; Nonaka H; Aoyama S; Kase H; Kumazawa T
J Med Chem; 1996 Dec; 39(26):5047-52. PubMed ID: 8978835
[TBL] [Abstract][Full Text] [Related]
27. Androgenic and anti-androgenic effects of progesterone derivatives with different halogens as substituents at the C-6 position.
Cabeza M; Gutiérrez E; Miranda R; Heuze I; Bratoeff E; Flores G; Ramírez E
Steroids; 1999 Jun; 64(6):413-21. PubMed ID: 10433178
[TBL] [Abstract][Full Text] [Related]
28. Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site.
Petrow V; Padilla GM; McPhail AT; Bruchovsky N; Schneider SL
J Steroid Biochem; 1989 Mar; 32(3):399-407. PubMed ID: 2704237
[TBL] [Abstract][Full Text] [Related]
29. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
[TBL] [Abstract][Full Text] [Related]
30. New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth.
Cabeza M; Bratoeff E; Heuze I; Rojas A; Terán N; Ochoa M; Ramírez-Apan T; Ramírez E; Pérez V; Gracia I
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):371-8. PubMed ID: 17059168
[TBL] [Abstract][Full Text] [Related]
31. New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor.
Garrido M; Bratoeff E; Bonilla D; Soriano J; Heuze Y; Cabeza M
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):367-73. PubMed ID: 21782943
[TBL] [Abstract][Full Text] [Related]
32. Novel 17 substituted pregnadiene derivatives as 5 alpha-reductase inhibitors and their binding affinity for the androgen receptor.
Cabeza M; Flores E; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Francolugo VA
Chem Pharm Bull (Tokyo); 2004 May; 52(5):535-9. PubMed ID: 15133203
[TBL] [Abstract][Full Text] [Related]
33. Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives.
Bratoeff EA; Herrera H; Ramírez E; Solorzano K; Murillo E; Quiróz A; Cabeza M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1249-55. PubMed ID: 10993221
[TBL] [Abstract][Full Text] [Related]
34. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies of 5 alpha-reductase inhibitors within MCF-7 human breast cancer cells.
MacIndoe JH; West ER; Petrow V
J Steroid Biochem; 1984 May; 20(5):1095-100. PubMed ID: 6727360
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
[TBL] [Abstract][Full Text] [Related]
37. Assignment of anabolic-androgenic and antiandrogenic properties to some chlorine-substituted steroids on the basis of their binding characteristics to the androgen receptor of the rat seminal vesicle.
Zakár T; Kaufmann G; Tóth M
Exp Clin Endocrinol; 1986 Jul; 87(2):133-41. PubMed ID: 3758193
[TBL] [Abstract][Full Text] [Related]
38. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
[TBL] [Abstract][Full Text] [Related]
39. FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.
Nakayama O; Hirosumi J; Chida N; Takahashi S; Sawada K; Kojo H; Notsu Y
Prostate; 1997 Jun; 31(4):241-9. PubMed ID: 9180934
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of some 4-fluoro- and 4-cyano derivatives of delta 4,3-ketosteroids as inhibitors of testosterone 5 alpha-reductase.
Jarman M; Barrie SE; Houghton J; Rowlands MG; Mann J; Haase-Held M; Hatzis M
J Enzyme Inhib; 1994; 8(1):17-23. PubMed ID: 7539066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
